Tower Research Capital (TRC)’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$86.4K Buy
5,769
+3,725
+182% +$55.8K ﹤0.01% 2502
2025
Q1
$33K Sell
2,044
-6,530
-76% -$105K ﹤0.01% 2547
2024
Q4
$200K Buy
8,574
+8,054
+1,549% +$187K ﹤0.01% 1717
2024
Q3
$15.3K Sell
520
-2,864
-85% -$84.2K ﹤0.01% 3415
2024
Q2
$79.6K Sell
3,384
-444
-12% -$10.4K ﹤0.01% 2753
2024
Q1
$145K Buy
3,828
+1,248
+48% +$47.3K ﹤0.01% 1618
2023
Q4
$55.5K Buy
2,580
+2,158
+511% +$46.4K ﹤0.01% 3060
2023
Q3
$5.17K Sell
422
-488
-54% -$5.98K ﹤0.01% 4752
2023
Q2
$10.3K Sell
910
-585
-39% -$6.6K ﹤0.01% 4119
2023
Q1
$11K Buy
1,495
+781
+109% +$5.75K ﹤0.01% 4267
2022
Q4
$8K Sell
714
-361
-34% -$4.05K ﹤0.01% 4455
2022
Q3
$14K Buy
1,075
+447
+71% +$5.82K ﹤0.01% 4228
2022
Q2
$8K Sell
628
-255
-29% -$3.25K ﹤0.01% 4711
2022
Q1
$51K Buy
883
+685
+346% +$39.6K ﹤0.01% 2716
2021
Q4
$24K Buy
198
+68
+52% +$8.24K ﹤0.01% 3478
2021
Q3
$26K Buy
130
+9
+7% +$1.8K ﹤0.01% 3489
2021
Q2
$21K Buy
121
+15
+14% +$2.6K ﹤0.01% 3855
2021
Q1
$21K Sell
106
-234
-69% -$46.4K ﹤0.01% 3848
2020
Q4
$67K Sell
340
-1,091
-76% -$215K ﹤0.01% 2788
2020
Q3
$254K Buy
1,431
+1,007
+238% +$179K ﹤0.01% 2337
2020
Q2
$98K Buy
+424
New +$98K ﹤0.01% 2480
2020
Q1
Sell
-292
Closed -$56K 3859
2019
Q4
$56K Buy
292
+235
+412% +$45.1K ﹤0.01% 1272
2019
Q3
$11K Buy
+57
New +$11K ﹤0.01% 2884
2019
Q1
Sell
-93
Closed -$17K 4262
2018
Q4
$17K Buy
93
+87
+1,450% +$15.9K ﹤0.01% 2069
2018
Q3
$1K Buy
+6
New +$1K ﹤0.01% 3627
2017
Q3
Sell
-9
Closed -$1K 4211
2017
Q2
$1K Buy
+9
New +$1K ﹤0.01% 2519
2017
Q1
Sell
-8
Closed -$1K 3890
2016
Q4
$1K Sell
8
-20
-71% -$2.5K ﹤0.01% 3661
2016
Q3
$5K Sell
28
-3
-10% -$536 ﹤0.01% 2576
2016
Q2
$4K Buy
+31
New +$4K ﹤0.01% 3559